Exosens stock

EXENS · Euronext Paris · EUR

Compare Exosens
€50.00Change from previous close: −4.85%Absolute change: −€2.55

Close · November 20, 2026

Price history

+11.36% over the period

1 year: from €44.90 (November 20, 2025) to €50.00 (November 20, 2026), +11.36%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026€50.00
October 30, 2026€56.90
September 30, 2026€59.80
August 31, 2026€58.05
July 31, 2026€57.20
June 30, 2026€57.10
May 29, 2026€68.15
April 30, 2026€64.85
March 31, 2026€61.20
February 27, 2026€62.30
January 30, 2026€53.90
December 31, 2025€48.45
November 28, 2025€41.95
November 20, 2025€44.90

At a glance

  • The company

    Develops and manufactures electro-optical technologies for defense, surveillance, life sciences, industrial and nuclear applications

  • Latest results

    Quarter to September 30, 2026

TickerLandia's take on Exosens

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low€40.00
52-wk high€74.00

−32.43% from the 52-week high

Analysts · 10 analysts

Average target€69.85+39.70% vs. price

Buy 8 · Hold 2 · Sell 0 · Buy

TickerLandia Fingerprint: Exosens

Compared with similar companies: weak momentum, high price, and high profitability.

Financials and price compared with 73 companies in the aerospace & defense industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Exosens is pricier than similar companies

Exosens's P/E (trailing 12 months): 119.0, +197% against the median of a group of 10 similar companies (40.0).

Compared with 10 similar companies

Exosens's metrics compared with similar companies
MetricExosensPosition in the groupBand
P/E (trailing 12 months)119.0High
Forward P/E20.5Middle
Operating margin17.4%High
ROE12.7%Middle
Debt/equity0.60Middle

Grey band: the middle half of the group; tick: the median; dot: Exosens. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

€253.07M

Latest quarter · Q2 2026

Net income

€15.34M

Latest quarter · Q2 2026

Quarterly net margin

6.1%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
€2.53B
P/E
119.0
EPS
€0.42
Volume
98.86K
Daily trading
€4.97M

How Exosens is changing

All results
  • Revenue grew 25.6% a year on average over the last 5 years

  • Operating margin rose from 15.0% to 22.2%

  • Profits turn into cash: free cash flow equal to 135% of net income

Returns

Exosens returns with dividends

€1,000 invested in Exosens 1 year ago, on November 20, 2025, would be worth €1,119 today with dividends reinvested: +11.89% in total, +11.89% per year. On price alone it would be €1,114 (+11.36%).

PeriodExosensCAC 40€1,000 becomes
1 month−12.97%+1.14%€870
6 months−18.57%−2.34%€814
Year to date+3.20%−2.72%€1,032
1 year+11.89%−0.67%€1,119

Over the last 6 months it has done better than 39% of the stocks in the Technology sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. CAC 40: price only. Calculate your investment

The chart in detail

Exosens: technical analysis

Exosens is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 31.4% below its all-time closing high (€72.90, March 18, 2026).

Trend
Downward
RSI (14 sessions)
35
Between 30 and 70
vs 200-session average
−16.92%

Active signals

  • Close below the low of the previous 55 sessions.

Support and resistance

Price areas where Exosens has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance€54.34+8.67%4 touches, last on October 8, 2026
  2. Resistance€52.70+5.40%2 touches, last on January 26, 2026
  3. Resistance€50.78+1.55%2 touches, last on June 26, 2026
  4. Last price€50.00
  5. No support below: the price is near the lows of the year

Volatility and risk

Over the last year it has moved less than the CAC 40.

Beta (1 year) vs CAC 40
0.42
Volatility (60 sessions, annualised)
43.0%
Largest fall in the last year
−31.41%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

The company

Exosens and its competitors

Its customers come from defense and surveillance, nuclear, industrial control, and life sciences and environment markets, and the company sells into France, the rest of Europe, North America, Asia and other international markets. Exosens designs, makes and sells electro-optical technologies organized in two segments: amplification, which covers image intensifier tubes, and detection and imaging, which spans cameras, sensors, imaging systems, and detectors for ions, electrons, photons and neutrons.

Headquarters
Mérignac, France
Employees
2,000
Founded
1937
Chief executive
Jerome Cerisier
Exosens and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
ExosensEXENS$2.78B17.4%119.0−18.57%
QinetiQ GroupQQ.$3.24B12.5%—+6.67%
LisiFII$3.3B9.8%35.1−1.72%
RENK GroupR3NK$3.36B10.7%44.9−36.13%
Exail TechnologiesEXA$2.35B7.4%25.9+2.69%
Theon InternationalTHEON$2.33B24.4%16.5−15.74%

Same industry or related industries, similar size. Compare Exosens with its competitors · Full profile